This inventor holds 1 USPTO granted patent. Top assignee: Fresenius Ag. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Innovations by Johannes Geibel in Blood Component Separation
Introduction
Johannes Geibel is an accomplished inventor based in Wadern, Germany. He has made significant contributions to the field of medical technology, particularly in the separation of blood components. His innovative approach aims to enhance the efficiency and purity of thrombocyte extraction, which is crucial for patient care.
Latest Patents
Geibel holds a patent for a "Method and apparatus for the separation of blood into its components." This invention focuses on a process and device that allows for the efficient extraction of a highly pure fraction of thrombocytes during density centrifugation of blood. The method eliminates the need for additional filtration before infusion, thereby reducing the risk of immunization in recipients. The invention employs a two-stage density separation process, where the first stage separates cells from thrombocyte-rich plasma. In the second stage, the thrombocyte-rich plasma is further processed to yield a concentrated thrombocyte solution with minimal leukocyte contamination. This innovative approach marks a significant advancement in blood component separation.
Career Highlights
Johannes Geibel is associated with Fresenius AG, a leading global healthcare group. His work at the company has allowed him to focus on developing technologies that improve patient outcomes through better blood component management. His dedication to innovation in this field has positioned him as a key figure in medical technology.
Collaborations
Geibel has collaborated with notable colleagues, including Wolfgang Biesel and Henning Brass. Their combined expertise has contributed to the advancement of technologies in blood separation and has fostered a collaborative environment for innovation.
Conclusion
Johannes Geibel's contributions to the field of blood component separation exemplify the impact of innovative thinking in healthcare. His patented methods not only enhance the efficiency of thrombocyte extraction but also prioritize patient safety. Through his work at Fresenius AG and collaborations with esteemed colleagues, Geibel continues to push the boundaries of medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile